Exploring perceptions of using preference elicitation methods to inform clinical trial design in rheumatology: A qualitative study and OMERACT collaboration

Semin Arthritis RheumPublished Qualitative study

Authors' conclusion

Our findings allowed us to consider the potential applications of patient preferences in trial design according to stakeholders within rheumatology who are involved in the trial process.

Study context

Population
Patients with rheumatic diseases and rheumatology clinicians/researchers
Participants
17 vs 9
Comparison
Patients vs Clinicians/researchers
  • Patientsn = 17
  • Clinicians/researchersn = 9
Outcome
Stakeholder perceptions of using preference elicitation methods to inform judgements when designing clinical trials in rheumatology
Methodological details1-on-1 semi-structured interviews, purposive and snowball sampling, thematic analysis, OMERACT collaboration, Interviews via Zoom, audio-recorded and transcribed; pre-interview video and document provided
  • 1-on-1 semi-structured interviews
  • Purposive and snowball sampling
  • Thematic analysis
  • OMERACT collaboration
  • Interviews via Zoom, audio-recorded and transcribed; pre-interview video and document provided

Main finding

As reported in the abstract

Themes: overall perceptions, barriers and facilitators
  • Patients and clinicians/researchers generally agreed that preference elicitation studies can improve clinical trial design, but many considerations are required around preference heterogeneity and feasibility
  • Key barrier: additional resources and expertise required to measure and incorporate preferences effectively in trial design
  • Key facilitators: guidance on using preference elicitation to inform trial design; role of external decision-makers in developing such guidance; leveraging the movement towards patient engagement in research
  • Data and inductive thematic saturation achieved within each group

Original publication

Exploring perceptions of using preference elicitation methods to inform clinical trial design in rheumatology: A qualitative study and OMERACT collaboration. Semin Arthritis Rheum. Published 3 November 2022. doi:10.1016/j.semarthrit.2022.152112

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.